Focus Financial Network’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-7,843
Closed -$218K – 712
2023
Q3
$218K Sell
7,843
-1,334
-15% -$43.6K 0.01% 541
2023
Q2
$313K Sell
9,177
-229
-2% -$7.2K 0.02% 456
2023
Q1
$283K Sell
9,406
-857
-8% -$26.6K 0.02% 462
2022
Q4
$290K Sell
10,263
-1,278
-11% -$40.6K 0.02% 379
2022
Q3
$379K Buy
11,541
+99
+0.9% +$3.63K 0.03% 331
2022
Q2
$360K Buy
11,442
+528
+5% +$18.5K 0.03% 350
2022
Q1
$501K Sell
10,914
-9,613
-47% -$458K 0.03% 302
2021
Q4
$1.26M Sell
20,527
-9,736
-32% -$673K 0.18% 118
2021
Q3
$2.26M Sell
30,263
-872
-3% -$73.2K 0.3% 85
2021
Q2
$2.88M Buy
31,135
+526
+2% +$44.7K 0.38% 67
2021
Q1
$2.72M Buy
30,609
+16,157
+112% +$1.6M 0.32% 74
2020
Q4
$1.35M Buy
14,452
+8,124
+128% +$647K 0.12% 150
2020
Q3
$403K Buy
6,328
+2,046
+48% +$120K 0.04% 290
2020
Q2
$223K Buy
+4,282
New +$184K 0.02% 358

Other funds holding ARKG

Focus Financial Network's ARKG Position: Q4 2023 in Review

Focus Financial Network sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 7,843 shares — an estimated $218K sold.

Focus Financial Network first reported a position in ARKG in Q2 2020 and held it in 14 quarters. The position peaked at $2.88M in Q2 2021. 300 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

  • Focus Financial Network reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
  • Focus Financial Network sold 7,843 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $218K.
  • Focus Financial Network first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 14 quarters.
  • Focus Financial Network's ARK Genomic Revolution ETF position peaked at $2.88M in Q2 2021.
  • 300 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Focus Financial Network's 13F filing for Q4 2023, filed 12 Feb 2024.